Neurologia medico-chirurgica
Online ISSN : 1349-8029
Print ISSN : 0470-8105
ISSN-L : 0470-8105
Volume 62, Issue 3
Displaying 1-8 of 8 articles from this issue
Original Articles
  • Eiichi SUEHIRO, Miwa KIYOHIRA, Kohei HAJI, Michiyasu SUZUKI, The Japan ...
    2022 Volume 62 Issue 3 Pages 111-117
    Published: 2022
    Released on J-STAGE: March 15, 2022
    Advance online publication: December 07, 2021
    JOURNAL OPEN ACCESS

    Neurological improvement occurs from the subacute to chronic phases in severe traumatic brain injury. We analyzed factors associated with improved neurological findings in the subacute phase, using data from the Japan Neurotrauma Data Bank (JNTDB). The subjects were 1345 patients registered in the JNTDB (Project 2015). Clinical improvement was evaluated by comparing the Glasgow Outcome Scale (GOS) at discharge and 6 months after injury. Of these patients, 157 with severe disability (SD) on the discharge GOS were examined to evaluate factors associated with neurological improvement in the subacute phase. Cases were defined as those with (group I) and without (group N) improvement: a change from SD at discharge to good recovery (GR) or moderate disability (MD) at 6 months after injury. Patient background, admission findings, treatment, and discharge destination were examined. In all patients, the favorable outcome (GR, MD) rate improved from 30.2% at discharge to 35.7% at 6 months after injury. Of SD cases at discharge, 44.6% had a favorable outcome at 6 months (group I). Patients in group I were significantly younger, and had a significantly lower D-dimer level in initial blood tests and a lower incidence of convulsions. In multivariate analysis, discharge to home was a significant factor associated with an improved outcome. Many SD cases at discharge ultimately showed neurological improvement, and the initial D-dimer level may be a predictor of such improvement. The environment after discharge from an acute care hospital may also contribute to an improved long-term prognosis.

    Download PDF (390K)
  • Ryuta YASUDA, Tetsu SATOW, Naoki HASHIMURA, Masaki NISHIMURA, Jun C. T ...
    2022 Volume 62 Issue 3 Pages 118-124
    Published: 2022
    Released on J-STAGE: March 15, 2022
    Advance online publication: December 08, 2021
    JOURNAL OPEN ACCESS

    While endovascular coil embolization has become one of the major therapeutic modalities for intracranial aneurysms, long-term imaging follow-up is required because of the higher rate of retreatment compared with surgical clipping. The purpose of this study was to show the usefulness of craniograms to discriminate coiled intracranial aneurysms that required retreatment. Under the study protocol approved by institutional review board, a retrospective review of the medical record was done regarding coil embolization for intracranial aneurysms performed between January 2014 and December 2018. Coil embolization performed as the initial treatment and followed up for more than 1 year without additional treatment, and those performed as retreatment after the initial coil embolization performed at our institution were recruited. Craniograms obtained just after the initial treatment were compared with those obtained just before the additional treatment in the retreated cases and compared with the latest ones in the non-recurrence cases. Correlation between the morphological changes in the coil mass on the craniograms and retreatments was evaluated. During the study period, 288 coil embolization procedures for intracranial aneurysms were performed. From these, 191 treatments that were followed up for more than 1 year without any additional treatments and 30 retreatments were included. Morphological change of the coil mass was observed in 4 of the 191 non-recurrence treatments and 26 of the 30 retreatments, which was significantly correlated with retreatments (p <0.001). Craniogram was a useful modality in following up the coiled intracranial aneurysms to detect those required retreatments.

    Download PDF (1827K)
  • Masaki IWASAKI, Keiya IIJIMA, Yutaro TAKAYAMA, Takahiro KAWASHIMA, His ...
    2022 Volume 62 Issue 3 Pages 125-132
    Published: 2022
    Released on J-STAGE: March 15, 2022
    Advance online publication: December 07, 2021
    JOURNAL OPEN ACCESS

    Considering that seizure freedom is one of the most important goals in the treatment of epilepsy, repeat epilepsy surgery could be considered for patients who continue to experience drug-resistant seizures after epilepsy surgery. However, the chance of seizure freedom is reported to be below 50% after reoperation for failed epilepsy surgery. This study aimed to elucidate the predictive factors for seizure outcomes after repeat pediatric epilepsy surgery. In all, 39 pediatric patients who underwent repeat curative epilepsy surgery between 2008 and 2020 at our institution were retrospectively studied. The relationship between preoperative clinical factors and postoperative seizure freedom at the last follow-up was statistically evaluated. The mean age at the first surgery was 5.5 years (0–16). The etiology of epilepsy was malformation of cortical development in 33 patients. The average time to seizure recurrence after the first surgery was 6.4 months (range, 0–26 months). In all, 16 patients (41.0%) achieved seizure freedom after the second surgery. Seven patients underwent a third surgery, and three (42.9%) achieved seizure freedom. Overall, 19 patients achieved seizure freedom after repeat epilepsy surgery (48.7%). Female sex, surgical failure due to technical limitations, congruent electroencephalography (EEG) findings, lesional magnetic resonance imaging (MRI) and Rt-sided surgery were predictive of seizure freedom, and surgery limited to the temporal lobe was predictive of residual seizures, as determined in the multivariate analysis. The reoperation of failed epilepsy surgery is challenging. Consideration of the above predictive factors can be helpful in deciding whether to reoperate on pediatric patients whose initial surgical intervention failed.

    Download PDF (535K)
  • Shu UTSUMI, Shima OHNISHI, Shunsuke AMAGASA, Ryuji SASAKI, Satoko UEMA ...
    2022 Volume 62 Issue 3 Pages 133-139
    Published: 2022
    Released on J-STAGE: March 15, 2022
    Advance online publication: December 08, 2021
    JOURNAL OPEN ACCESS

    Repeat head computed tomography (RHCT) is common and routine for pediatric traumatic brain injury (TBI) patients. In mild (Glasgow Coma Scale; GCS 13–15) to moderate (GCS 9–12) TBI, recent studies have shown that RHCT without clinical deterioration does not alter management. However, the effectiveness of routine RHCT for pediatric TBI patients under 2 years has not been investigated. This study aims to investigate whether routine RHCT changes management in mild-to-moderate TBI patients under 2 years. We performed a retrospective review at the emergency department of the National Center for Child Health and Development between January 2015 and December 2019. Mild-to-moderate TBI patients under 2 years with an acute intracranial injury on initial head CT scan and receiving follow-up CT scans were included. Mechanism, severity of TBI, indication for RHCT, and their findings were listed. Study outcome was intervention based on the findings of RHCT. Intervention was defined as intubation, ICP monitor placement, or neurosurgery. We identified 50 patients who met inclusion criteria and most patients (48/50) had mild TBI. The most common mechanism was ‘fall’ (68%). Almost all RHCT was routine and the overall incidence of radiographic progression on RHCT was 12%. RHCT without clinical deterioration did not lead to intervention, although one patient with moderate TBI required intervention due to radiographic progression with clinical symptoms. Our study showed that routine RHCT without clinical deterioration for mild TBI patients under 2 years may not alter clinical management. We suggest that RHCT be considered when there is clinical deterioration such as decrease in GCS.

    Download PDF (947K)
Technical Notes
  • Yasutaka IMADA, Chie MIHARA
    2022 Volume 62 Issue 3 Pages 140-148
    Published: 2022
    Released on J-STAGE: March 15, 2022
    Advance online publication: December 07, 2021
    JOURNAL OPEN ACCESS

    In the interhemispheric approach (IHA) for the distal anterior cerebral artery (DACA) aneurysms, the surgical trajectory to a DACA aneurysm is very important because surgeons sometimes encounter the intraoperative disorientation and the premature rupture. The purpose of this study was to clarify the anatomical landmarks indicating the trajectory to the genu of the corpus callosum (GCC) at the early stage of dissection for the correct intraoperative orientation. “Point A” was defined as the crossing point between the frontal bone and the line connecting the projected external acoustic opening (EAO) and the GCC on the midline slice of the sagittal three-dimensional computed tomography angiography (3D-CTA) images. We measured the distance from the nasion to Point A using midline sagittal slice images from 50 patients who underwent 3D-CTA at our institution. The average distance was 7.0 cm (±0.3 cm). Therefore, the direction of the spatula inserted in the direction of the EAO from Point A (7 cm above the nasion) corresponds to the trajectory to the GCC. In DACA aneurysms of the A3 segment, the pericallosal artery distal to the aneurysm can be safely identified by dissecting the interhemispheric fissure distal to the trajectory to the GCC. In DACA aneurysms of the A4 or A5 segment, the parent artery of the aneurysm can be safely identified by dissection along the trajectory to the GCC. Point A and the EAO can be used as landmarks indicating the trajectory to the GCC for the correct intraoperative orientation in the IHA for DACA aneurysms.

    Download PDF (4916K)
  • Jiro OHARA, Motoaki FUJIMOTO, Shoichi TANI, Hideki OGATA, Kampei SHIMI ...
    2022 Volume 62 Issue 3 Pages 149-155
    Published: 2022
    Released on J-STAGE: March 15, 2022
    Advance online publication: December 08, 2021
    JOURNAL OPEN ACCESS

    We describe three cases with acute middle cerebral artery (MCA) occlusion. From the pre-operative MRI, including three-dimensional turbo spin-echo sequences using T1WI and T2WI, we assessed both thrombus configuration and arterial anatomy at the MCA bifurcations. For efficient endovascular thrombectomy, we identified the applied MCA segment 2 (M2) branch, in which the main thrombus was buried. Sufficient recanalization after a single pass was achieved and the patients made a marked recovery. Although mechanical thrombectomy for M2 occlusion has not been of proven benefit, the endovascular procedure based on three-dimensional turbo spin-echo imaging is useful for more complete thrombus removal at MCA bifurcations.

    Download PDF (1780K)
Rapid Communication
  • Shinichi YOSHIMURA, Kazutaka UCHIDA, Nobuyuki SAKAI, Hiroshi YAMAGAMI, ...
    2022 Volume 62 Issue 3 Pages 156-164
    Published: 2022
    Released on J-STAGE: March 15, 2022
    Advance online publication: December 24, 2021
    JOURNAL OPEN ACCESS

    Endovascular therapy is strongly recommended for acute cerebral large vessel occlusion (LVO) with an Alberta stroke program early computed tomography score (ASPECTS) ≥6 due to occlusion of the internal carotid artery or M1 segment of the middle cerebral artery. However, the effect of endovascular therapy for patients with a large ischemic core with an ASPECTS ≤5 (0–5) was not established. A multicenter, randomized, open-label, parallel-group trial was conducted to investigate the superiority of endovascular therapy over medical therapy without endovascular therapy for a large ischemic core with ASPECTS (3–5). Patients were randomly assigned to receive endovascular therapy or without endovascular therapy at a ratio of 1:1. The primary outcome was a moderate functional outcome, defined as a modified Rankin scale (mRS; scores ranging from 0 [no symptoms] to 6 [death]) ≤3 after 90 days. The secondary outcomes were defined as ordinal mRS, good functional outcome (mRS ≤2), excellent functional outcome (mRS ≤1), mRS shift analysis after 90 days, and early improvement of neurological findings at 48 hours. A total sample size of 200 was estimated to provide a power of 0.9 with a two-sided alpha of 0.05, for the primary outcome, considering a 15% dropout rate. This randomized clinical trial reported the applicability of endovascular therapy in patients with acute cerebral LVO with a large ischemic core.

    Download PDF (240K)
Editorial Committee
feedback
Top